Safety Notices

From time to time notices relating to the safety and/or quality of medicinal products are published by the Health Products Regulatory Authority

These notices are classified under several priority related categories and may relate to human and veterinary medicines, or medical devices.   

The issues covered by these notices will range from quality defect information and medicinal product safety information through to updated information on the appropriate usage of medicines or devices.

Notices are categorised in accordance with their importance at time of publication.

The four notice categories are outlined as follows:

  • Advisory  -  Routine safety information            
  • Warning  -  Urgent safety information
  • Recall  -  Urgent safety information relating to a product recall
  • Publications  -  General safety information provided by the HPRA for publication via 3rd parties e.g. MIMS

The HPRA Drug Safety Newsletter is also published on a regular basis.

Date Title Type
22/11/2019 Lucentis (ranibizumab) - Important Safety Information from Novartis Europharm Ltd as approved by the HPRA 3rd Party Publications
21/11/2019 Medicinal Product Shortages - update - 21 November 2019 Advisory
13/11/2019 HPRA MIMS Articles November 2019 3rd Party Publications
13/11/2019 Medicinal Product Shortages - update - 13 November 2019 Advisory
06/11/2019 Medicinal Product Shortages - update - 6 November 2019 Advisory
30/10/2019 Medicinal Product Shortages - update - 30 October 2019 Advisory
23/10/2019 Medicinal Product Shortages - update - 23 October 2019 Advisory
17/10/2019 HPRA MIMS Articles October 2019 3rd Party Publications
16/10/2019 Medicinal Product Shortages - update - 16 October 2019 Advisory
15/10/2019 Mitomycin-C Kyowa 40 mg - Important Safety Information from Kyowa Kirin Holdings B.V. as approved by the HPRA 3rd Party Publications